MABVAX THERAPEUTICS HOLDINGS, INC. (NASDAQ:MBVX) Files An 8-K Submission of Matters to a Vote of Security Holders

MABVAX THERAPEUTICS HOLDINGS, INC. (NASDAQ:MBVX) Files An 8-K Submission of Matters to a Vote of Security Holders

Story continues below

Item 5.07. Submission of Matters to a Vote of Security Holders.

The following proposals were voted on by our stockholders at the
2017 Annual Meeting of Stockholders (Annual Meeting), which was
held on June 12, 2017, at 10:00 a.m. local time. At the Annual
Meeting, a total of 3,783,824 shares, or 58.81%, of the Companys
common stock issued and outstanding as of the record date for the
Annual Meeting, including Series D Convertible Preferred Stock,
Series E Convertible Preferred Stock, and Series F Convertible
Preferred Stock voting on an as-converted basis, subject to
certain voting limitations set forth in the respective governing
Certificates of Designation, were represented in person or by
proxy. Set forth below is a brief description of each matter
voted upon at the Annual Meeting and the voting results with
respect to each matter.
1) To elect two Class II directors to serve until the 2020 Annual
Meeting of Stockholders;
Nominee
Votes For
Votes Against
Abstain
Broker Non-Votes
Jeffrey F. Eisenberg
1,674,516
0
247,645
1,861,663
Jeffrey V. Ravetch
1,674,795
0
247,366
1,861,663
The nominees were elected.
2) To grant the Board of Directors the authority, in its sole
direction, to amend the Companys Third Amended and Restated 2014
Employee, Director and Consultant Equity Incentive Plan to
increase the number of shares available for issuance thereunder
to 4,128,406 from 2,159,352;
Votes For
Votes Against
Abstain
Broker Non-Votes
1,641,895
277,205
3,061
1,861,663
The proposal was approved.
3) To ratify the appointment of CohnReznick LLP as our
independent registered public accounting firm for our fiscal year
ending December 31, 2017;
Votes For
Votes Against
Abstain
3,491,223
254,663
37,938
The proposal was approved.
4) To authorize the adjournment of the Annual Meeting if
necessary or appropriate, including soliciting additional proxies
in the event that there are not sufficient votes at the time of
the Annual Meeting or adjournment or postponement thereof to
approve any of the foregoing proposals.
Votes For
Votes Against
Abstain
3,258,950
518,715
6,159
The proposal was approved.
An ad to help with our costs